Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challenges

INTRODUCTION: Poor or inconsistent adherence to daily oral pre-exposure prophylaxis (PrEP) has emerged as a key barrier to effective HIV prevention. The advent of potent long-acting (LA) antiretrovirals (ARVs) in conjunction with advances in controlled release technologies has enabled LA ARV drug de...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrahari, Vivek, Anderson, Sharon M., Peet, M. Melissa, Wong, Andrew P., Singh, Onkar N., Doncel, Gustavo F., Clark, Meredith R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639748/
https://www.ncbi.nlm.nih.gov/pubmed/36252277
http://dx.doi.org/10.1080/17425247.2022.2135699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639748/
https://www.ncbi.nlm.nih.gov/pubmed/36252277
http://dx.doi.org/10.1080/17425247.2022.2135699

Ejemplares similares